Changes of the clinical presentation of abruptio placentae.
There is an increase of the diagnosis "a.p." during the last years, especially stage 0 + 1. Qualified US monitoring seems to be responsible for this fact. Abruptio placentae is reversible in some cases. Conservative management can be done under intensive care conditions if antenatal treatment is indicated.
D000037:Abruptio Placentae / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D001623:Betamethasone / Q000627:therapeutic use; D003422:Critical Care; D004211:Disseminated Intravascular Coagulation / Q000209:etiology; D005260:Female; D005280:Fenoterol / Q000627:therapeutic use; D005865:Gestational Age; D006406:Hematoma / Q000209:etiology; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011379:Prognosis; D014463:Ultrasonography
D005280:Fenoterol; D001623:Betamethasone